Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study. [electronic resource]
Producer: 20090819Description: 793-800 p. digitalISSN:- 1476-5365
- Adult
- Aged
- Boronic Acids -- administration & dosage
- Bortezomib
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Hematopoietic Stem Cell Mobilization
- Herpesvirus 3, Human -- drug effects
- Humans
- Killer Cells, Natural -- drug effects
- Lymphocyte Subsets
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Multiple Myeloma -- drug therapy
- Peripheral Blood Stem Cell Transplantation -- methods
- Pyrazines -- administration & dosage
- Remission Induction
- Survival Analysis
- T-Lymphocytes, Cytotoxic -- drug effects
- Transplantation, Autologous
- Treatment Outcome
- Virus Activation -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.